Cardiac arrhythmias impact millions of people across the globe, increasing the risk of serious health-related issues, including stroke and even death.¹ Yet, the current standard of care — including antiarrhythmic drugs and blind, anatomical-based ablation therapy — is suboptimal and is associated with severe side effects and disappointingly low success rates.²

‍Vektor Medical, Inc. aims to revolutionize arrhythmia therapy with a transformative technology focused on our understanding of cardiac arrhythmias. Vektor’s technology is designed to supplement clinical management of arrhythmias by providing physicians with actionable information to evaluate, locate, and potentially treat the arrhythmia using its non-invasive, rapid, and workflow-optimized “vMap™” technology.